The PE Ratio as of September 2024 (TTM) for Curis, Inc. (CRIS) is -0.61

According to Curis, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.61. This represents a change of -47.70% compared to the average of -1.17 of the last 4 quarters.

Curis, Inc. (CRIS) Historical PE Ratio (quarterly & annually)

How has CRIS PE Ratio performed in the past?

The mean historical PE Ratio of Curis, Inc. over the last ten years is -4.62. The current -0.61 PE Ratio has changed 1.22% with respect to the historical average. Over the past ten years (40 quarters), CRIS's PE Ratio was at its highest in in the March 2020 quarter at -0.62. The PE Ratio was at its lowest in in the December 2017 quarter at -71.57.

Curis, Inc. (CRIS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Curis, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Curis, Inc. (CRIS) Average PE Ratio

How has CRIS PE Ratio performed in the past?

The current PE Ratio of Curis, Inc. (CRIS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Curis, Inc. (CRIS) PE Ratio vs. Peers

How is CRIS’s PE Ratio compared to its peers?

Curis, Inc.’s PE Ratio is greater than Aileron Therapeutics, Inc. (-2.21), less than Artelo Biosciences, Inc. (-0.58), less than Histogen Inc. (-0.10), less than Timber Pharmaceuticals, Inc. (-0.07), less than X4 Pharmaceuticals, Inc. (7.41), greater than Mereo BioPharma Group plc (-18.18), greater than Inozyme Pharma, Inc. (-3.48), greater than Terns Pharmaceuticals, Inc. (-6.06), greater than Leap Therapeutics, Inc. (-1.83), greater than Day One Biopharmaceuticals, Inc. (-7.39), greater than PDS Biotechnology Corporation (-2.64), greater than Adaptimmune Therapeutics plc (-3.82), greater than Pieris Pharmaceuticals, Inc. (-0.93), greater than Affimed N.V. (-0.66), greater than Corvus Pharmaceuticals, Inc. (-10.64), less than Aptose Biosciences Inc. (-0.15),

Build a custom stock screener for Curis, Inc. (CRIS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curis, Inc. (CRIS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.